Anti-CD86 (B7.2) Treatment abolishes allergic airway hyperresponsiveness in mice

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 5 I, 1999, Pages 1638-1643

  Haczku, Angela ^b   Takeda, Katsuyuki ^b   Redai, Imre ^b   Hamelmann, Eckard ^b   Cieslewicz, Gregory ^b   Joetham, Anthony ^b   Loader, Joan ^b   Lee, James J ^b   Irvin, Charles ^b   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; OVALBUMIN;

ALLERGY TEST; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; ASTHMA; CELL INTERACTION; EOSINOPHILIA; FEMALE; INFLAMMATORY CELL; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE;

EID: 0032914146     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.5.9711040     Document Type: Article

References (30)

1. Schweitzer, A. N., and A. H. Sharpe. 1998. The complexity of the B7-CD28/CTLA-4 costimulatory pathway. Agents Actions Suppl. 49:33-43.
2. Cross, A. H., T. J. Girard, K. S. Giacoletto, R. J. Evans, R. M. Keeling, R. F. Lin, J. L. Trotter, and R. W. Karr. 1995. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J Clin. Invest. 95:2783-2789.
3. Jenkins, M. K., P. S. Taylor, S. D. Norton, K. B. Urdahl. 1991. CD28 delivers a coslimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461-2466.
4. Padrid, P. A., M. Mathur, X. Li, K. Herrmann, Y. Qin, A. Cattamanchi, J. Weinstock, D. Elliott, A. I. Sperling, and J. A. Bluestone. 1998. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 18:453-462.
5. Keane-Myers, A., W. C. Cause, P. S. Linsley, S.-J. Chen, and M. Wills-Karp. 1997. B7-CD28/CTLA-4 costimulatory pathways arc required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158:2042-2049.
6. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7.1 and B7.2 costimulatory molecules activate differentially the Th2/Th2 developmental pathways: application to autoimmune disease. Cell 80: 707-718.
7. Lenschow, D., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobcsc diabetic mouse. J. Exp. Med. 181:1145-1155.
8. Harris, N., R. Peach, J. Naemura, P. Linsley, G. Le Gros, and F. Ronchese. 1997. CD80 costimulation is essential for the induction of airway eosinophilia. J Exp. Med. 185:177-182.
9. Tsuyuki, S., J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyle 1997. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp. Med. 185:1671-1679.
10. Keane-Myers, A. M., W. C. Gause, F. D. Finkelman, X. D. Xhou, and M Wills-Karp. 1998. Development of murine allergic asthma is dependent upon B7-2 costimulation. J. Immunol. 160:1036-1143.
11. Lack G., K. L. Bradley, E. Hamelmann, H. Renz, J. Loader, D. Y. Leung, G. L. Larsen, and E. W. Gelfand. 1996. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol. 157:1432-1439.
12. Haczku, A., P. MacAry, E. B. Haddad, T. J. Huang, D. M. Kemeny, R. Moqbel, and K. F. Chung. 1996. Expression of Th2 cytokines interleukin-4 and -5 and of Th1 cytokine interferon-γ in ovalbumin-exposed sensitized Brown-Norway rats. Immunology 88:247-251.
13. Lee, J. J., M. P. McGarry, S. C. Farmer, K. L. Denzler, K. A. Larson, P. E. Carrigan, I. E. Brenneise, M. A. Horton, A. Haczku, E. W. Gelfand, G. D. Leikauf, and N. A. Lee. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143-2156.
14. Saloga, J., H. Renz, G. Lack, K. L. Bradley, J. L. Greenstein, G. Larsen, and E. W. Gelfand. 1993. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. J. Clin. Invest. 91:133-140.
15. Haczku, A., P. MacAry, T. J. Huang, H. Tsukagoshi, P. J. Barnes, A. B. Kay, D. M. Kemeny, K. F. Chung, and R. Moqbel. 1997. Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in Brown-Norway rats. Immunology 91:176-185.
16. + T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J. Exp. Med. 183:1719-1729.
17. Hamelmann, E., A. Oshiba, J. Schwarze, K. Bradley, J. Loader, G. L. Larsen, and E. W. Gelfand. 1997. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 16(6):674-682.
18. Larsen, G. L., H. Renz, J. E. Loader, K. L. Bradley, and E. W. Gelfand. 1992. Airway response to electric field stimulation in sensitized inbred mice. Passive transfer of increased responsiveness with peribronchial lymph nodes. J. Clin. Invest. 89:747-752.
19. Haczku, A., K. Takeda, E. Hamelmann, A. Oshiba, J. Loader, A. Joctham, C. Irvin, H. Kikutani, and E. W. Gelfand. 1997. CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalburnin. Am. J. Respir. Crit. Care Med. 156(6): 1945-1955.
20. Wagner, D. H., J. Hagman, P. S. Linsley, W. Hodsdon, J. H. Freed, and M. K. Newell. 1996. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with R7-1/B7-2. J. Exp. Med. 184:1631-1638.
21. Hamelmann, E., A. T. Vella, A. Oshiba, J. W. Kappler, P. Marrack, and E. W. Gelfand. 1997. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 94:1350-1355.
22. Gelfand, E. W., A. T. Vella, P. Marrack, and E. Hamelmann. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness (AHR) in allergen-sensitized B-cell deficient mice. J. Allergy Clin. Immunol. 99:S266.
23. Schwarze, J., E. Hamelmann, K. L. Bradley, K. Takeda, and E. W. Gelfand. 1997. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J. Clin. Invest. 100:226-233.
24. Greenwald, R. J., P. Lu, M. J. Halvorson, X. Zhou, S. Chen, K. B. Madden, P. J. Perrin, S. C. Morris, F. D. Finkelman, R. Peach, P. S. Linsley, J. F. Urban, and W. C. Gause. 1997. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J. Immunol. 158:4088-4096.
25. Hofer, M. F., O. Jirapongsananuruk, A. E. Trumble, and D. Y. Leung. 1998. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J. Allergy Clin. Immunol. 101:96-102.
26. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Renncrt, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523-532.
27. Lenschow, D., G.-T. Su, L. Zuckerman, N. Nabavi, C. L. Jellis, G. S. Gray, J. Miller, and J. A. Bluestone. 1993. Expression and functional significance of an additional ligand forCTLA-4. Proc. Natl. Acatl. Sci. U.S.A. 90:11054-11058.
28. Levine, B., Y. Ueda, N. Craighead, M. Huang, and C. June. 1995. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokinc secretion in vitro. Int. Immunol. 7:891-904.
29. Schweitzer, A., F. Borriello, R. Wong, A. Abbas, and A. Sharpe. 1997. Role of costimulators in T cell differentiation. J Immunol. 158:2713-2722.
30. Tao, X., S. Constant, P. Jorritsma, and K. Bottomly. 1997. Strength of TCR signal determines the costimulatory requirements for Thl and Th2 CD4+ T cell differentiation. J Immunol. 159(12):5956-5963.